Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.

Bar & Bench

Published:23rd Aug, 2021 at 3:39 PM

Mynvax, a vaccine technology startup, incubated by the Society for Innovation and Development (SID) has raised $4.2 million (₹31 crores) in its Series A funding round led by Accel.

Argus Partners advised Mynvax and the team was led by Partner Vinod Joseph along with Associate Anurag Prasad.

IndusLaw acted for Accel and the team was led by Partner Anindya Ghosh. along with Principal Associate Ashwin Krishnan and Associate Manisha Nayak.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.

Also Read

Delhi Riots: Court acquits 6 accused of arson near mosque, slams Delhi Police for fabricating evidence

PIL filed before Delhi High Court to implement Delhi Panchayati Raj Act

Kerala High Court ropes in Legal Services Authorities to visit government hospitals, check shortcomings

Kerala High Court grants protection from arrest to actress Lakshmi Menon in abduction case

"Justice must not sink": Floods in J&K submerge Anantnag court but judge reaches by boat to pass orders